Saturday, October 3, 2026

EUR/JPY Is 2% Down In The Last 21 Sessions

ViaNews Editorial Team

August 22, 2024

EUR/JPY Is 2% Down In The Last 21 Sessions

(VIANEWS) - EUR/JPY (EURJPY) has been up by 2.5% for the last 21 sessions. At 19:06 EST on Thursday, 22 August, EUR/JPY (EURJPY) is $162.40.

Eur/jpy price forecast: the next bullish target to watch is above 162.50

The EUR/JPY cross holds positive ground around 162.00 during the early European session on Thursday. , EUR/JPY keeps the bearish vibe unchanged on the 4-hour chart as the cross is currently below the key 100-period Exponential Moving Averages (EMA).

EUR/JPY's yearly highs and lows, it's 9.885% up from its 52-week low and 7.419% down from its 52-week high.

Volatility

EUR/JPY's last week, last month's, and last quarter's current intraday variation average was a negative 0.09%, a negative 0.22%, and a positive 0.40%, respectively.

EUR/JPY's highest amplitude of average volatility was 0.48% (last week), 0.60% (last month), and 0.40% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/JPY's Forex is considered to be overbought (>=80).

Previous days news about EUR/JPY (EURJPY)

  • Eur/jpy jumps to 163.00 amid notable JPY supply, looks to final eurozone CPI for some impetus. According to FXStreet on Tuesday, 20 August, "The EUR/JPY cross rallied nearly 130 pips from the Asian session low, around the 161.70 region and spikes to a fresh daily peak in the last hour amid the emergence of fresh selling around the Japanese Yen (JPY). ", "Investors now look forward to the release of the final Eurozone CPI print, which might influence the Euro and produce some short-term trading opportunities around the EUR/JPY cross."
  • Eur/jpy rises to near 162.00 due to record trade deficit in Japan, eurozone PMI eyed. According to FXStreet on Wednesday, 21 August, "This upside of the EUR/JPY cross could be attributed to the tepid Japanese Yen (JPY) following the release of Trade Balance data on Wednesday."
  • Eur/jpy bounces back to 162.50 as yen corrects with national CPI in focus. According to FXStreet on Wednesday, 21 August, "The EUR/JPY pair rebounds sharply from the intraday low of 161.40 to near 162.50 in Wednesday's European session. "

More news about EUR/JPY (EURJPY).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com